New Key Statistics Module, Z-Score and F-Score
OTCPK:DCHPF Key Ratios
| Market Cap $ M | 5,342.19 |
| Enterprise Value $ M | 5,889.05 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 40.91 |
| Forward PE Ratio | -- |
| Price/Book | 5.83 |
| Price/Sales | 5.79 |
| Price/Free Cash Flow | 131.95 |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.48 |
| Revenue (TTM) $ M | 944.00 |
| EPS (TTM) $ | -0.32 |
| Beneish M-Score | -2.63 |
| 10-y EBITDA Growth Rate % | 13.00 |
| 5-y EBITDA Growth Rate % | 3.10 |
| y-y EBITDA Growth Rate % | -47.90 |
| EV-to-EBIT | 619.41 |
| EV-to-EBITDA | 49.55 |
| PEG | 13.20 |
| Shares Outstanding M | 113.91 |
| Net Margin (%) | -3.66 |
| Operating Margin % | 0.83 |
| Pre-tax Margin (%) | -4.74 |
| Quick Ratio | 1.53 |
| Current Ratio | 2.85 |
| ROA % (ttm) | -1.82 |
| ROE % (ttm) | -3.70 |
| ROIC % (ttm) | 0.36 |
| Dividend Yield % | 0.33 |
| Altman Z-Score | 4.05 |
DCHPF Number of Guru Trades
DCHPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:DCHPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:DCHPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Dechra Pharmaceuticals PLC Insider Transactions
No Available Data
News about OTCPK:DCHPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers